Ensembl is currently experiencing issues
The Ensembl REST API is temporarily unavailable. Some gene data (transcript details, protein domains) may be incomplete. Other data sources are unaffected.
You can check Ensembl's status at status.ensembl.org
RNU2-2
Chr 11ADARRNA, U2 small nuclear 2
Also known as: DEE119, RNU2-2P, RNU2B, U2
Primary Disease Associations & Inheritance
Clinical highlights
Some data sources returned errors (2)
ensembl: Error: Ensembl fetch failed: 400 for /lookup/symbol/homo_sapiens/RNU2-2?content-type=application/json
gnomad: Error: Gene not found
Population Genetics & Constraint
Constraint data not available from gnomAD.
ClinVar Variant Classifications
0 submitted variants in ClinVar
Mechanism of Pathogenicity
Splicing / LOFvariant-dependentNon-coding U2 spliceosomal snRNA (not a protein — gene-level protein-mechanism predictors do not apply). Heterozygous de novo variants (e.g. n.4, n.35) cause a dominant developmental and epileptic encephalopathy, thought to act by disrupting spliceosome function (aberrant splicing via altered U6/branch-site interactions) rather than haploinsufficiency. Separately, biallelic variants cause a clinically distinct — and notably prevalent — recessive disorder through loss of function: they destabilise the snRNA and reduce U2-2 expression by >90%. Mechanism is therefore variant- and zygosity-dependent.
References: PMID 40909831, PMID 40950445
Expert-curated annotation. Non-coding RNA gene — protein-based mechanism predictors (Badonyi & Marsh) do not apply.
External Resources
Links to major genomics databases and tools
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
No active trials found for this gene.
Search ClinicalTrials.gov →Trials that enrol by condition rarely name the gene: developmental and epileptic encephalopathy
External Resources
Links to major genomics databases and tools